MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home test AAIQOL (Activity and Affect Indicators of QOL)
 AAIQOL (Activity and Affect Indicators of QOL)

Developed by:
Steven Albert (USA)

Objective:
To assess quality of life in dementia

Copyright:
AAIQOL © Steven M. Albert, 1996 - All rights reserved.

Reference publications:
Albert SM, Castillo-Castenada C, Sano M, Jacobs DM, Marder K, Bell K, Lafleche G, Brandt J, Albert M, Stern Y. "Quality of life in patients with Alzheimer's disease as reported by patient proxies." J Amer Geriatrics Soc, 44:1342-1347, 1996.


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.

2. Access fees:

carre6 Author's royalty fee : the use of the AAIQOL in commercial studies is subject to Steven Albert's royalties fees, of an amount 500 US$ per study and per language version requested.
Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:
- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 250 €* per study + 20 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 70 €* per language  
   version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).

Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on the AAIQOL on PROQOLID

[ BACK ]
 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France)

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PI-ED (Paediatric Index of Emotional Distress)
GL Assessment (UK)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SATMED-Q (Treatment Satisfaction with Medicines Questionnaire)
The EACCOS Group (Spain)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA)


To access our catalog, please click here.



Coming soon!


Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)



For any information, please contact:
contact@mapi-trust.org